Mostrar el registro sencillo del ítem
| dc.contributor.author | Balgoma Hernando, David | |
| dc.contributor.author | Perttersson, Curt | |
| dc.contributor.author | Hedeland, Mikael | |
| dc.date.accessioned | 2025-01-29T14:32:02Z | |
| dc.date.available | 2025-01-29T14:32:02Z | |
| dc.date.issued | 2019 | |
| dc.identifier.citation | Trends Endocrinol Metab . 2019 May;30(5):283-285 | es |
| dc.identifier.issn | 1043-2760 | es |
| dc.identifier.uri | https://uvadoc.uva.es/handle/10324/74591 | |
| dc.description | Producción Científica | es |
| dc.description.abstract | Recent studies have reported the upregulation of a subgroup of triacylglycerides as markers of different diseases with dysregulated lipogenesis, which means that these markers are not selective. This observation has a deep impact on their use as diagnostic tools in clinical practice (e.g., markers of risk of type 2 diabetes). | es |
| dc.format.mimetype | application/pdf | es |
| dc.language.iso | eng | es |
| dc.publisher | CellPress | es |
| dc.rights.accessRights | info:eu-repo/semantics/restrictedAccess | es |
| dc.title | Common Fatty Markers in Diseases with Dysregulated Lipogenesis | es |
| dc.type | info:eu-repo/semantics/article | es |
| dc.identifier.doi | 10.1016/J.TEM.2019.02.008 | es |
| dc.relation.publisherversion | https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(19)30041-4 | es |
| dc.identifier.publicationfirstpage | 283 | es |
| dc.identifier.publicationissue | 5 | es |
| dc.identifier.publicationlastpage | 285 | es |
| dc.identifier.publicationtitle | Trends in Endocrinology & Metabolism | es |
| dc.identifier.publicationvolume | 30 | es |
| dc.peerreviewed | SI | es |
| dc.type.hasVersion | info:eu-repo/semantics/submittedVersion | es |
